Actively Recruiting
Invasive Hemodynamic Control Cohort for The Mayo Clinic Adult Congenital Heart Disease Registry
Led by Mayo Clinic · Updated on 2026-05-05
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Mayo Clinic
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to provide comparative data for the Mayo Clinic Adult Congenital Heart Disease Registry by studying both healthy individuals and those with congenital heart disease. The study is observational and focuses on gathering important baseline information related to heart and lung function. Participants will be observed without receiving any specific treatment or intervention. The study involves collecting data to measure pulmonary vascular reserve at baseline, which helps researchers understand heart and lung blood flow under different conditions. During the study, participants will undergo assessments such as MRI scans and blood pressure measurements. Kidney function will be confirmed through recent lab results. Participants will be monitored for factors that might influence the heart and lung function measurements. The study is expected to continue until December 2026, with ongoing data collection at regular intervals.
CONDITIONS
Brief Title
A Study of Invasive Hemodynamic for MACHD Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to give informed consent
- Body mass index (BMI) 30 or less
- Systolic blood pressure 140 mmHg or less
- Diastolic blood pressure 90 mmHg or less
- Estimated glomerular filtration rate (eGFR) above 30 within the prior 3 months
- Able to undergo MRI scanning
You will not qualify if you...
- History of cardiovascular disease that may affect test results
- Current orthopedic limitations
- Currently taking any cardiac medications
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single timepoint
Participants undergo invasive hemodynamic assessments as part of the study procedures.
1 visit (in-person)
Duration - Up to 4 years
Participants are observed over time to assess pulmonary vascular reserve and related outcomes.
Trial Site Locations
Total: 1 location
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
A
ACHD Research Program
A
Alexander Egbe, MBBS, MPH
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here